MARKET

MTACU

Medtech Acquisition Corp
MTACU
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-436.4807
-
14.76
283,750,000.00
Trisalus Life Sciences, Inc. Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023
Press release · 04/11 22:33
Medtech Acquisition Corp: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Press release · 08/10/2023 21:24
Medtech Acquisition Corp: Current report
Press release · 08/09/2023 13:01
Medtech Acquisition Corp: Prospectuses and communications, business combinations
Press release · 08/09/2023 13:01
Medtech Acquisition Corp: Current report
Press release · 08/03/2023 00:01
Medtech Acquisition Corp: Prospectuses and communications, business combinations
Press release · 08/03/2023 00:01
Medtech Acquisition Corp: Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Press release · 08/03/2023 00:01
Medtech Acquisition Corp: Quarterly report
Press release · 08/02/2023 11:01
More

Webull offers Medtech Acquisition Corp stock information, including NASDAQ: MTACU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTACU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MTACU stock methods without spending real money on the virtual paper trading platform.